Guggenheim reiterates Neutral rating on Checkpoint Software stock By Investing.com

Guggenheim kept a Neutral rating on Check Point Software and sees limited upside to first-quarter revenue, with risk around consensus total revenue despite some billings upside. The firm said field checks improved from Q4 2025 but remain mixed, and it still sees no clear path to double-digit top-line growth; Check Point reports Q1 2026 results on April 30. The stock trades at 4.7x next-twelve-month recurring revenue and 8.8x free cash flow, while Cantor Fitzgerald also cut its price target to $175 from $190 and kept Neutral.

Analysis

CHKP is in the uncomfortable middle of a cycle transition: the business still prints elite margins, but the growth engine is being pulled forward rather than truly expanded. That matters because a hardware-driven demand bump from pricing fear usually normalizes quickly; once the channel has stocked ahead of memory inflation, the next quarter or two can look softer even if underlying security demand is fine. In other words, the near-term setup is more about billing timing than durable ARR acceleration, which caps multiple expansion.

The second-order winner is FTNT and PANW, not because they are immune to the same end-demand dynamics, but because they have more operating leverage to product-led share capture when enterprises rush purchases to avoid cost increases. If Check Point is under-indexing to the pull-forward, it likely signals weaker channel pull or less pricing power in the appliance stack. That can bleed into competitive perception in the field, where partner confidence tends to compound over several quarters rather than one print.

The key risk is a short, violent relief rally if billings beat while revenue merely lands in range: the stock can squeeze on headline beats even if the medium-term growth path remains unimpressive. The more important horizon is 3-6 months, where management commentary on AI security attach rates and subscription mix will determine whether CHKP stays a cash-yield compounder or re-rates higher. If they fail to show a credible path to sustained double-digit top-line growth, the market will keep paying down the multiple despite quality fundamentals.

Key Decisions for Investors

• Stay neutral-to-underweight CHKP into earnings; use any post-print pop on a billings beat to fade strength if forward guide does not inflect. Risk/reward favors selling into relief rallies rather than pre-positioning for a clean breakout.
• Prefer a relative long FTNT / short CHKP pair for the next 1-2 quarters. FTNT should have better upside to appliance demand pull-forward and channel recovery; stop if CHKP shows unexpected subscription acceleration or FTNT channel checks deteriorate.
• Prefer a long PANW / short CHKP pair on any broader cybersecurity dip. PANW has the cleaner AI/security narrative and should capture more budget reallocation if enterprises consolidate vendors; the trade works best after earnings volatility settles.
• If CHKP gaps down on earnings despite fair-quality margins, consider selling 1-2 month puts only at strikes where EV/NTM FCF is materially below peers. The thesis is valuation support, not growth acceleration, so premium selling is the better expression than outright long equity.
• Do not chase the AI partnership headlines as a standalone catalyst. Treat them as medium-term option value; the stock needs evidence of monetization within 2-3 quarters before that narrative should influence position size.